Skip to content

Evaluation of the Effectiveness of Music Therapy on Anxiety Levels in Patients With Advanced Cancer Hospitalized in a Palliative Care Unit

Evaluation of the Effectiveness of Music Therapy on Anxiety Levels in Patients With Advanced Cancer Hospitalized in a Palliative Care Unit

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07806435
Acronym
CessataEl'ansi
Enrollment
84
Registered
2026-09-08
Start date
2026-10-01
Completion date
2028-04-01
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Cancer, Music Therapy, Palliative Care

Keywords

anxiety, Music therapy, palliative care, cancer

Brief summary

A music therapy intervention can be either receptive or active. In both cases, somatic effects have been observed, with a direct impact on respiratory, cardiac and hemodynamic parameters, as well as psychological effects, creating a relationship of support, accompaniment and listening to the person. An intervention protocol using Kigonki has been developed and validated by the University Diploma in Music Therapy team at Paul-Valéry Montpellier 3 University (DUMM3). Studies on music therapy in palliative care have been published, but there is still a need for large controlled studies assessing the prolonged effect of a standardized intervention. This randomized clinical is designed for patients with terminal cancer pathology, hospitalized in palliative care units and with anxiety and depression scores both above 11 on the Hospital Anxiety and Depression scale (HAD). The primary endpoint is change in anxiety score. Patients included in the experimental arm will be offered the above-mentioned protocol with 3 weekly sessions of receptive music therapy with Kigonki for 2 weeks, after drawing up an intervention plan. Anxiety/depression levels will be measured before and 30 minutes after each session, as well as one week after the last session. Patients in the reference arm will have their anxiety/depression level monitored 3 times a week. In both arms, the study will be terminated at the end of the last protocol evaluation (i.e., at 3 weeks). If anxiety worsens (score rises by 2 points), a music therapy intervention similar to that performed for patients of the experimental arm may be proposed to patients of the reference arm. This project requires the participation of 84 patients, which seems feasible at the inter-regional level in 7 centers over 18 months.

Interventions

\- Management of anxiety, pain, and depression according to the usual pharmacological and non-pharmacological practices of each center.

OTHERKigonki

Six 30-minute sessions of receptive ISM with Kigonki according to study protocol

OTHERquestionnaire

Assessment of PANAS questionnaire, TSAI test, digital scale measurement, physiological constants (pulse, blood pressure, respiratory rate) 3 times a week for 2 weeks, then 7 days after the last of these 6 assessments.

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER
Centre Hospitalier de Bethune
CollaboratorNETWORK
Centre Hospitalier de Douai
CollaboratorOTHER
Hospital of Lens
CollaboratorUNKNOWN
GHPSO site de Senlis
CollaboratorUNKNOWN
CH de Compiegne
CollaboratorUNKNOWN
Centre Hospitalier de Beauvais
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Patient hospitalized in palliative care unit for oncological pathology * Presenting an anxiety score \> 46 (according to the STAI-Y State scale) * Whose subsequent hospitalization is estimated to last more than three weeks * No deafness likely to interfere with a receptive music therapy session (no difficulty in understanding whispered speech). * Affiliated with a social security scheme * Have signed the consent form for the study

Exclusion criteria

* Deafness without hearing aids * Patients under guardianship, curatorship or safeguard of justice * Pregnant or breast-feeding * Not affiliated to a social security scheme * Patient with an aversion to the sounds produced by the Kigonki

Design outcomes

Primary

MeasureTime frameDescription
change in anxiety score obtained using the STAI-Y State scale1 weekThe State-Trait Anxiety Inventory (STAI), specifically Form Y (STAI-Y), stands as one of the most widely utilized self-report measures in psychological and medical research for the quantitative assessment of anxiety. The STAI-Y operationalizes the psychological construct of anxiety as having two independent dimensions, each measured by 20 items for a total of 40 items in the complete inventory. State Anxiety (A-State) is defined as a transient emotional response characterized by immediate, subjective feelings of tension, apprehension, worry, and physiological activation of the autonomic nervous system. Respondents assess their feelings "right now, at this moment" using a 4-point intensity scale. In contrast, Trait Anxiety (A-Trait) refers to stable individual differences in anxiety proneness. Individuals scoring high in A-Trait are predisposed to perceive a broader range of situations as threatening and are likely to react to these situations with elevated A-State responses. A-Trait

Secondary

MeasureTime frame
respiratory rate30 minutes after the session
PANAS questionnaire (Positive and Negative Affect Scale)30 minutes after the session
Variations in scores of the STAI-Y ETAT scale30 minutes after the session
pulse variation30 minutes after the session
BP variation30 minutes after the session

Countries

France

Contacts

CONTACTJulie Oncle, MD
Oncle.julie@chu-amiens.fr33+03 22 45 64 43

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026